Trademark: 79325581
Word
VYMADA
Status
Registered
Status Code
700
Status Date
Tuesday, May 24, 2022
Serial Number
79325581
Registration Number
6733993
Registration Date
Tuesday, May 24, 2022
Mark Type
4000
Filing Date
Tuesday, October 5, 2021
Published for Opposition
Tuesday, March 8, 2022

Trademark Owner History
Novartis AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
In the statement, line 1, "Joint Stock Company" should be deleted, and Aktiengesellschaft should be inserted.

Trademark Events
Sep 11, 2022
Notification Processed By Ib
Aug 24, 2022
Final Disposition Notice Sent To Ib
Aug 23, 2022
Final Disposition Processed
Aug 22, 2022
Correction Under Section 7 ¿ Processed
Aug 21, 2022
Assigned To Paralegal
Jun 22, 2022
Teas Section 7 Request Received
Jun 23, 2022
Grant Of Protection Created, To Be Sent To Ib
May 24, 2022
Notice Of Registration Confirmation Emailed
May 24, 2022
Registered-Principal Register
Mar 22, 2022
Changes/Corrections After Pub Approval Entered
Mar 18, 2022
Assigned To Petition Staff
Mar 13, 2022
Notification Processed By Ib
Mar 10, 2022
Teas Post Publication Amendment Received
Mar 8, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 8, 2022
Published For Opposition
Feb 16, 2022
Notification Of Possible Opposition Sent To Ib
Feb 16, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 16, 2022
Notification Of Notice Of Publication E-Mailed
Feb 1, 2022
International Registration Renewed
Jan 26, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 26, 2022
Teas Change Of Correspondence Received
Jan 26, 2022
Teas Change Of Domestic Representatives Address
Jan 26, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 26, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 26, 2022
Teas Change Of Owner Address Received
Jan 26, 2022
Assigned To Lie
Jan 26, 2022
Approved For Pub - Principal Register
Jan 21, 2022
Assigned To Examiner
Nov 27, 2021
Application Filing Receipt Mailed
Nov 23, 2021
New Application Office Supplied Data Entered In Tram
Nov 22, 2021
Limitation From Original Application Entered
Nov 11, 2021
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24